SCHEMBL12897643

SCHEMBL12897643

COc1ccccc1C1CCN(C2CCCC(C)C2)CC1

nearest known ligand 0.64

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.64
DRD2 P14416 1/20 0.52
TSHR P16473 1/20 0.52
MEN1 O00255 7/20 0.51
KMT2A Q03164 7/20 0.51
HTR2C P28335 2/20 0.49
MCOLN2 Q8IZK6 1/20 0.48
MCOLN3 Q8TDD5 1/20 0.48
MCOLN1 Q9GZU1 1/20 0.48
TRPV6 Q9H1D0 1/20 0.47
CHRM4 P08173 2/20 0.46
CHRM1 P11229 2/20 0.46
ABCB1 P08183 1/20 0.46
CHRM2 P08172 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12896515 1.00 ALDH1A1 (0.64) ALDH1A1DRD2TSHRMEN1KMT2A
SCHEMBL12897275 0.92 DRD2 (0.55) ALDH1A1DRD2MEN1KMT2AHTR2C
SCHEMBL12897089 0.92 DRD2 (0.55) ALDH1A1DRD2MEN1KMT2AHTR2C
SCHEMBL12896502 0.87 DRD2 (0.56) ALDH1A1DRD2MEN1KMT2AHTR2C
SCHEMBL12896451 0.87 MEN1 (0.59) DRD2MEN1KMT2AHTR2CMCOLN2
SCHEMBL12897136 0.86 MEN1 (0.61) DRD2MEN1KMT2AHTR2CMCOLN2
SCHEMBL12896742 0.86 MEN1 (0.61) DRD2MEN1KMT2AHTR2CMCOLN2
SCHEMBL7890862 0.86 MEN1 (0.61) DRD2MEN1KMT2AHTR2CMCOLN2
SCHEMBL12896884 0.85 TRPV6 (0.56) DRD2MEN1KMT2AHTR2CMCOLN2
Hydrochloric Acid SCHEMBL7879546 0.85 MEN1 (0.60) DRD2MEN1KMT2AHTR2CMCOLN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7880007-B2 such as 1-bicyclo[2.2.1]hept-2-yl-4-(4-methoxy-2-methyl-phenyl)-piperidine, used for the treatment of chronic obstructive pulmonary disease, asthma, urinary incontinence, vision defects and Alzheimer's disease VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-02-01 US disclosed
US-7880007-B2 such as 1-bicyclo[2.2.1]hept-2-yl-4-(4-methoxy-2-methyl-phenyl)-piperidine, used for the treatment of chronic obstructive pulmonary disease, asthma, urinary incontinence, vision defects and Alzheimer's disease VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-02-01 US disclosed